Michael Lang

550 total citations
21 papers, 409 citations indexed

About

Michael Lang is a scholar working on Pathology and Forensic Medicine, Neurology and Molecular Biology. According to data from OpenAlex, Michael Lang has authored 21 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 5 papers in Neurology and 4 papers in Molecular Biology. Recurrent topics in Michael Lang's work include Multiple Sclerosis Research Studies (10 papers), Peripheral Neuropathies and Disorders (4 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). Michael Lang is often cited by papers focused on Multiple Sclerosis Research Studies (10 papers), Peripheral Neuropathies and Disorders (4 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). Michael Lang collaborates with scholars based in Germany, United States and Austria. Michael Lang's co-authors include Scott E. Brietzke, Arnfin Bergmann, Stefan Braune, Andreas Harth, Antonios Bayas, Frank Weber, Markus Naumann, Hayrettin Tumani, Herbert Schreiber and Fredrik Nyberg and has published in prestigious journals such as Journal of Biological Chemistry, Neurology and International Journal of Molecular Sciences.

In The Last Decade

Michael Lang

21 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Lang Germany 10 190 95 86 71 62 21 409
Naoto Takahashi Japan 10 143 0.8× 129 1.4× 26 0.3× 33 0.5× 18 0.3× 41 542
Lihua Zhang China 12 72 0.4× 79 0.8× 33 0.4× 29 0.4× 33 0.5× 36 335
Joseph Bruno Bidin Brooks Brazil 12 228 1.2× 73 0.8× 36 0.4× 10 0.1× 102 1.6× 36 409
An‐Kuo Chou Taiwan 15 33 0.2× 222 2.3× 53 0.6× 59 0.8× 14 0.2× 34 518
Aaron M. Fields United States 12 30 0.2× 194 2.0× 37 0.4× 71 1.0× 15 0.2× 25 517
Valentina Pierini Italy 11 54 0.3× 150 1.6× 43 0.5× 28 0.4× 10 0.2× 31 484
Amer Awad United States 7 285 1.5× 45 0.5× 52 0.6× 15 0.2× 127 2.0× 14 430
Ashok Poluri United States 13 72 0.4× 144 1.5× 128 1.5× 51 0.7× 22 0.4× 18 722
Antonio Martı́nez-Yélamos Spain 12 279 1.5× 71 0.7× 44 0.5× 14 0.2× 157 2.5× 33 451
Erika Lerch Switzerland 9 65 0.3× 62 0.7× 63 0.7× 71 1.0× 33 0.5× 19 510

Countries citing papers authored by Michael Lang

Since Specialization
Citations

This map shows the geographic impact of Michael Lang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Lang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Lang more than expected).

Fields of papers citing papers by Michael Lang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Lang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Lang. The network helps show where Michael Lang may publish in the future.

Co-authorship network of co-authors of Michael Lang

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Lang. A scholar is included among the top collaborators of Michael Lang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Lang. Michael Lang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hackl, Simon, et al.. (2018). Sternumfrakturen – Rippenfrakturen. Orthopädie und Unfallchirurgie up2date. 13(6). 571–592. 1 indexed citations
2.
3.
4.
5.
Schreiber, Herbert, et al.. (2015). Is Personality Profile a Relevant Determinant of Fatigue in Multiple Sclerosis?. Frontiers in Neurology. 6. 2–2. 25 indexed citations
6.
Braune, Stefan, et al.. (2015). Efficacy of fingolimod is superior to injectable disease modifying therapies in second-line therapy of relapsing remitting multiple sclerosis. Journal of Neurology. 263(2). 327–333. 22 indexed citations
7.
Lang, Michael, Andreas Harth, Markus Naumann, et al.. (2015). Listeria Meningitis Complicating Alemtuzumab Treatment in Multiple Sclerosis—Report of Two Cases. International Journal of Molecular Sciences. 16(7). 14669–14676. 64 indexed citations
8.
Limmroth, Volker, Wilhelm Haverkamp, Ralf Dechend, et al.. (2015). First Dose Effects of Fingolimod: An in-depth Analysis of the first 2500 START Patients (S4.005). Neurology. 84(14_supplement). 2 indexed citations
9.
Trenkwalder, Claudia, Monica Canelo, Heike Beneš, et al.. (2015). First 1-year Real-life Study to Assess Management of Augmentation of Restless Legs Syndrome by Switching to Rotigotine Transdermal System (P7.304). Neurology. 84(14_supplement). 2 indexed citations
10.
Lang, Michael, et al.. (2014). Patient Preferences In The Choice Of Disease Modifying Drugs For Multiple Sclerosis (P3.137). Neurology. 82(10_supplement). 2 indexed citations
11.
Braune, Stefan, et al.. (2013). Second line use of Fingolimod is as effective as Natalizumab in a German out-patient RRMS-cohort. Journal of Neurology. 260(12). 2981–2985. 37 indexed citations
12.
Milanov, Ivan, et al.. (2013). ExtaviJect® 30G device for subcutaneous self-injection of interferon beta-1b for multiple sclerosis: a prospective European study. Medical Devices Evidence and Research. 6. 175–175. 17 indexed citations
13.
Lang, Michael & Scott E. Brietzke. (2013). A Systematic Review and Meta‐analysis of Endoscopic Balloon Dilation of Pediatric Subglottic Stenosis. Otolaryngology. 150(2). 174–179. 57 indexed citations
14.
15.
Lang, Michael, et al.. (2010). Optimizing Immunomodulatory Therapy with Interferon Beta in Patients with Multiple Sclerosis. International Journal of MS Care. 12(4). 147–154. 2 indexed citations
16.
Lang, Michael, et al.. (2008). Steigerung der Therapietreue durch ein Therapiebegleitprogramm bei Multipler Sklerose. Nervenheilkunde. 27(9). 818–822. 2 indexed citations
17.
Malats, Núria, Fredrik Nyberg, Wolfgang Ahrens, et al.. (2000). Lung cancer risk in nonsmokers and GSTM1 and GSTT1 genetic polymorphism.. PubMed. 9(8). 827–33. 73 indexed citations
18.
Deecke, L., et al.. (1987). Cerebral potentials preceding and accompanying verbal and spatial tasks.. PubMed. 40. 17–23. 9 indexed citations
19.
Loh, Y. Peng, et al.. (1985). Regulation of pro-opiomelanocortin synthesis by dopamine and cAMP in the amphibian pituitary intermediate lobe.. Journal of Biological Chemistry. 260(15). 8956–8963. 25 indexed citations
20.
Friedman, Yochanan, Michael Lang, & Gerald Burke. (1981). Role of guanine nucleotides in the stimulation of thyroid adenylate cyclase by prostaglandin E1 and cholera toxin. Biochimica et Biophysica Acta (BBA) - General Subjects. 673. 114–123. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Naoto Takahashi Breakdown of academic impact, for papers by Lihua Zhang Breakdown of academic impact, for papers by Joseph Bruno Bidin Brooks Breakdown of academic impact, for papers by An‐Kuo Chou Breakdown of academic impact, for papers by Aaron M. Fields Breakdown of academic impact, for papers by Valentina Pierini Breakdown of academic impact, for papers by Amer Awad Breakdown of academic impact, for papers by Ashok Poluri Breakdown of academic impact, for papers by Antonio Martı́nez-Yélamos Breakdown of academic impact, for papers by Erika Lerch
Rankless by CCL
2026